A Search Service for Abbreviation / Long Form

■ Search Result - Abbreviation : CTLA-4

Search Conditions:
Search Keyword : CTLA-4
Search Method : Exact match.
Research Area:

Results:  
Hit abbr.: 2 kinds.
(Click one to see its hit entries.)

(Appearance freq, Descending)
Abbreviation: CTLA-4
Appearance Frequency: 2402 time(s)
Long forms: 23

Display Settings:
[Entries Per Page]
 per page
Page Control
Page: of
Long Form No. Long Form Research Area Co-occurring Abbreviation PubMed/MEDLINE Info. (Year, Title)
cytotoxic T-lymphocyte-associated antigen 4
(1244 times)
Neoplasms
(298 times)
PD-1 (248 times)
PD-L1 (143 times)
ICIs (52 times)
1995 Binding stoichiometry of the cytotoxic T lymphocyte-associated molecule-4 (CTLA-4). A disulfide-linked homodimer binds two CD86 molecules.
cytotoxic T-lymphocyte antigen-4
(1079 times)
Allergy and Immunology
(264 times)
PD-1 (182 times)
PD-L1 (77 times)
OR (57 times)
0 [Non-Small Cell Lung Cancer - from Immunobiology to Immunotherapy].
CTL-associated antigen 4
(26 times)
Neoplasms
(14 times)
CTLs (3 times)
TME (3 times)
DC (2 times)
2004 CTLA-4-dependent mechanisms prevent T cell induced-liver pathology during the erythrocyte stage of Plasmodium berghei malaria.
CTL antigen 4
(13 times)
Neoplasms
(11 times)
PD-1 (3 times)
PD-L1 (2 times)
CR (1 time)
2003 Efficient expansion of regulatory T cells in vitro and in vivo with a CD28 superagonist.
cytotoxic T cell antigen 4
(12 times)
Neoplasms
(3 times)
OR (3 times)
PD-1 (2 times)
SNPs (2 times)
2003 Multivalent RNA aptamers that inhibit CTLA-4 and enhance tumor immunity.
CTL-associated protein 4
(5 times)
Neoplasms
(2 times)
BTLA (2 times)
PD-1 (2 times)
Tim-3 (2 times)
2009 Invariant natural killer T cells regulate breast cancer response to radiation and CTLA-4 blockade.
anti-CTL antigen-4
(4 times)
Neoplasms
(4 times)
mAb (2 times)
PD-1 (2 times)
GITR (1 time)
2006 Combination therapy with anti-CTL antigen-4 and anti-4-1BB antibodies enhances cancer immunity and reduces autoimmunity.
anti-cytotoxic T-lymphocyte 4
(2 times)
Allergy and Immunology
(1 time)
ICI (1 time)
IL (1 time)
IMDC (1 time)
2018 Immune correlates of clinical outcome in melanoma.
cell lymphocyte-associated molecule-4
(2 times)
Genetics
(1 time)
ATD (1 time)
HT (1 time)
TRAb (1 time)
2002 Remission of Graves' hyperthyroidism and A/G polymorphism at position 49 in exon 1 of cytotoxic T lymphocyte-associated molecule-4 gene.
10  cytotoxic T lymphocyte Ag-4
(2 times)
Allergy and Immunology
(2 times)
SEB (1 time)
1997 Signals through 4-1BB are costimulatory to previously activated splenic T cells and inhibit activation-induced cell death.
11  anti-cytotoxic T-lymphocyte antigen-4 monoclonal
(1 time)
Neoplasms
(1 time)
--- 2013 An abscopal response to radiation and ipilimumab in a patient with metastatic non-small cell lung cancer.
12  case of autoimmune hypophysitis induced by the anticytotoxic T-lymphocyte antigen-4
(1 time)
Endocrinology
(1 time)
irAE (1 time)
2015 Anticytotoxic T-lymphocyte antigen-4 induced autoimmune hypophysitis: a case report and literature review.
13  change in the levels of T-lymphocyte-associated antigen 4
(1 time)
Neurosurgery
(1 time)
ELISA (1 time)
GKR (1 time)
PD-L1 (1 time)
2019 Gamma knife radiosurgery compared to whole brain radiation therapy enhances immunity via immunoregulatory molecules in patients with metastatic brain tumours.
14  checkpoint inhibitors, namely anticytotoxic T-lymphocyte antigen-4
(1 time)
ACTH (1 time)
MRI (1 time)
NSCLC (1 time)
2018 Two Cases of Atezolizumab-Induced Hypophysitis.
15  clarify the role of the T-lymphocyte-associated-4
(1 time)
Endocrinology
(1 time)
Ab (1 time)
AITD (1 time)
RFLP (1 time)
2003 Association of the CTLA-4 gene 49 A/G polymorphism with type 1 diabetes and autoimmune thyroid disease in Japanese children.
16  combinations of the following monoclonal antibodies: CD3-PE/cy5, CD4-APC, CD8-APC, CD152-PE
(1 time)
Medicine
(1 time)
CHB (1 time)
PBMCs (1 time)
PD-L1 (1 time)
2013 CTLA-4 and its ligands on the surface of T- and B-lymphocyte subsets in chronic hepatitis B virus infection.
17  common T lymphocyte antigen 4
(1 time)
Drug Therapy
(1 time)
PD-1 (1 time)
2015 The genetic basis of new treatment modalities in melanoma.
18  cytokine suppressors such as T lymphocyte-associated antigen-4
(1 time)
Complementary Therapies
(1 time)
ELISA (1 time)
ICOS (1 time)
IFN-gamma (1 time)
2012 Repressor of GATA-3 can negatively regulate the expression of T cell cytokines through modulation on inducible costimulator.
19  cytotoxic T cell associated antigen-4
(1 time)
Chemistry
(1 time)
MAPK (1 time)
MEK (1 time)
PD-L1 (1 time)
2020 Current Insights into Combination Therapies with MAPK Inhibitors and Immune Checkpoint Blockade.
20  cytotoxic T lymphocyte associated antigen receptor-4
(1 time)
Biomedical Engineering
(1 time)
DC (1 time)
IL-6 (1 time)
SAM (1 time)
2010 Dendritic cell responses to self-assembled monolayers of defined chemistries.
21  Cytotoxic T-cell Associated Protein 4
(1 time)
Hematology
(1 time)
LAG-3 (1 time)
MCL (1 time)
PD-1 (1 time)
2019 Modulation of immune checkpoint molecule expression in mantle cell lymphoma.
22  cytotoxic T-cell-associated Ag-4
(1 time)
Cells
(1 time)
BM-MSCs (1 time)
DT-MSCs (1 time)
GVHD (1 time)
2019 Mesenchymal Stem/Stromal Cells Derived from Dental Tissues: A Comparative In Vitro Evaluation of Their Immunoregulatory Properties Against T cells.
23  cytotoxic T-lymphocyte attenuator-4
(1 time)
Communicable Diseases
(1 time)
LAG-3 (1 time)
PD-1 (1 time)
2015 Induction of Inhibitory Receptors on T Cells During Plasmodium vivax Malaria Impairs Cytokine Production.